Related Experiment Video

Updated: Jul 10, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Using the new cholesterol guidelines in everyday practice

D L Sprecher1, J P Frolkis

  • 1Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA. sprechd@ccf.org

Cleveland Clinic Journal of Medicine
|July 17, 2001
PubMed

Insights

The updated National Cholesterol Education Program (NCEP) guidelines refine cardiovascular risk assessment. High-risk patients, including those with existing diseases or high coronary event risk, require specific lipid management strategies.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Previous National Cholesterol Education Program (NCEP) guidelines established risk-based cholesterol management.
  • The 2001 NCEP Adult Treatment Panel III (ATP III) guidelines represent a significant update.
  • Lipid management strategies are evolving based on comprehensive patient risk assessment.

Purpose of the Study:

  • To outline the key changes and recommendations in the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III).
  • To detail the refined methodology for cardiovascular risk assessment introduced in the 2001 guidelines.
  • To emphasize the importance of integrating lipid levels with patient risk status for effective treatment decisions.

Main Methods:

  • The guidelines classify patients into risk categories based on established cardiovascular diseases and calculated 10-year coronary event risk.
  • A refined scoring method is employed to determine a patient's 10-year risk of a coronary event.
  • Specific conditions, including coronary artery disease, diabetes mellitus, and peripheral vascular disease, are used to define the highest-risk group.

Main Results:

  • The 2001 NCEP ATP III guidelines introduce a more nuanced approach to cardiovascular risk stratification.
  • Patients with known coronary artery disease, diabetes, or other specific vascular diseases are categorized as highest risk.
  • A 10-year coronary event risk exceeding 20%, determined by a scoring method, also designates patients as highest risk.

Conclusions:

  • The NCEP ATP III guidelines provide an updated framework for managing cholesterol and cardiovascular risk.
  • Accurate risk assessment is crucial for tailoring lipid-lowering therapies.
  • These guidelines aim to improve patient outcomes by optimizing the management of dyslipidemia in high-risk individuals.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...